SINGAPORE, July 7, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the...
Read More Details
Finally We wish PressBee provided you with enough information of ( SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V )
Also on site :